Skip to main content
. 2023 Feb 15;110(3):516–530. doi: 10.1016/j.ajhg.2023.01.016

Table 2.

Clinical outcomes of ICSI cycles with spermatozoa from men harboring hemizygous SSX1 variants

Individual N027 II-1 H054 II-1 Y1642 II-1 Y7460 II-1 AY001 II-1 S868 II-1
Male age (years) 29 26 22 32 31 31
Female age (years) 25 28 21 32 29 35
Number of ICSI cycle 1 1 1 1 1
Number of oocytes injected 5 15 14 28 15
Number (and rate) of fertilized oocytes 5 (100.0%) 14 (93.0%) 12 (86.0%) 27 (96.4%) 14 (93.3%)
Number (and rate) of cleavage embryos 5 (100.0%) 14 (100.0%) 12 (100.0%) 26 (96.3%) 14 (100.0%)
Number (and rate) of 8-cells 4 (80.0%) 11 (78.6%) 10 (83.3%) 20 (74.1%) 12 (85.7%)
Number (and rate) of blastocysts 8 (57.1%) 10 (83.3%) 12 (44.4%) 9 (64.3%)
Number of transfer cycle(s) 1 1 1 1 2
Number of embryo(s) transferred per cycle 2 2 2 1 1
Implantation rate 0.0% 100.0% 50.0% 100.0% 0.0%
Clinical pregnancy rate 0.0% 100.0% 100.0% 100.0% 0.0%
Miscarriage rate 0.0% 0.0% 0.0%

‒, not applicable.